Breaking Down Information Silos
1 Michael A. Swit, Esq. Vice President. The Forgotten Keys to Bio-Pharma Transactions – Regulatory, Clinical & Quality Challenges in Due Diligence and.
Speakers
Drug Safety and FDA “Revitalization” Legislation Dan Kracov August 23, 2007 FDA Regulatory and Compliance Symposium.
THE FDA REGULATORY AND COMPLIANCE SYMPOSIUM Managing Risks – From Pipeline to Patient
One Company’s Steps to Compliance: Pfizer’s Oversight & Education to Avoid Conflicts of Interest
